由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
Stock版 - Big-Cap Biotech Stocks Plumb Lowest Valuations in 10 Years
相关主题
腰鼓爆拉到8月初It might be good idea to add biotech now
生物科技股为啥集体跳水?为什么BIIB跌这么多?
Biotech板块的近期走势分析 (转载)还是MRK给力
GILD今天跌了,可以买吗?哭死USU飞了
Gild目标价格,85想买些abt
今天为何一把好牌给打烂了?我的生物科技股 完蛋了
今天IBB真顽强biotech好像调整完了
捞IBB, short QQQ下周大盘及看好个股(10/20/14 - 10/24/14)
相关话题的讨论汇总
话题: biotech话题: cap话题: stocks话题: big话题: lowest
进入Stock版参与讨论
1 (共1页)
g******n
发帖数: 1536
1
Biotech stocks have been pummeled in recent months, but get this: the most
mature companies in the industry: Gilead Sciences (GILD), Amgen (AMGN),
Celgene (CELG) and Biogen (BIIB) are trading at their lowest collective
valuation in a decade.
That’s according to Mark Schoenebaum, biotech analyst at Evercore ISI. He
blasted a valuation chart to clients on Thursday, which shows a rarity: big-
cap biotech stocks have a lower price-to-earnings ratio, based on estimates
for the next 12 months, than the S&P 500. That’s almost never happened
since 2006. Barron’s Johanna Bennett argued yesterday that Biogen was
looking cheap relative to its earnings potential.
The iShares Nasdaq Biotechnology exchange-traded fund(IBB) is market-cap
weighted, and therefore heavy on the big boys. The SPDR S&P Biotech ETF (XBI
), on the other hand, gives equal weight to large and small caps alike. It’
s fallen nearly 30% so far this month alone -- about seven percentage points
more that the market-cap weighted ETF.
g******n
发帖数: 1536
2
最近bio为什么这么惨?还有希望吗?

big-
estimates

【在 g******n 的大作中提到】
: Biotech stocks have been pummeled in recent months, but get this: the most
: mature companies in the industry: Gilead Sciences (GILD), Amgen (AMGN),
: Celgene (CELG) and Biogen (BIIB) are trading at their lowest collective
: valuation in a decade.
: That’s according to Mark Schoenebaum, biotech analyst at Evercore ISI. He
: blasted a valuation chart to clients on Thursday, which shows a rarity: big-
: cap biotech stocks have a lower price-to-earnings ratio, based on estimates
: for the next 12 months, than the S&P 500. That’s almost never happened
: since 2006. Barron’s Johanna Bennett argued yesterday that Biogen was
: looking cheap relative to its earnings potential.

a*****s
发帖数: 26
3
A.MM已经有内幕知道接下来more regulation,earning会显著下降
B.板块轮动,抄能源去了
C.panic selling 企稳之后会迅速反弹
大家信哪个?
b****5
发帖数: 449
4
A不可能,每节上台政府都要说药价,最后只是把价格搞得更高。P民一会就忘记了。
B有可能的,Timing might affect sector in short-term.
C估计要等等,不过很明显现在panic了。AMGN才出了财报,Beat on EPS/Rev,
Increase Outlook,又尼玛崩。这不是有病吗。
如果说医保高,Administrative Cost 和Hospital才贵呢,先从这个动手才对。
a*****s
发帖数: 26
5
恩,新年以来我的xbi仓位损失不小,forward PE才15,准备企稳之后average down

【在 b****5 的大作中提到】
: A不可能,每节上台政府都要说药价,最后只是把价格搞得更高。P民一会就忘记了。
: B有可能的,Timing might affect sector in short-term.
: C估计要等等,不过很明显现在panic了。AMGN才出了财报,Beat on EPS/Rev,
: Increase Outlook,又尼玛崩。这不是有病吗。
: 如果说医保高,Administrative Cost 和Hospital才贵呢,先从这个动手才对。

1 (共1页)
进入Stock版参与讨论
相关主题
下周大盘及看好个股(10/20/14 - 10/24/14)Gild目标价格,85
Gild要不要割?请大牛给个建议今天为何一把好牌给打烂了?
GILD今天IBB真顽强
今天可以捞捞IBB, short QQQ
腰鼓爆拉到8月初It might be good idea to add biotech now
生物科技股为啥集体跳水?为什么BIIB跌这么多?
Biotech板块的近期走势分析 (转载)还是MRK给力
GILD今天跌了,可以买吗?哭死USU飞了
相关话题的讨论汇总
话题: biotech话题: cap话题: stocks话题: big话题: lowest